Top Markets
#1 ADO Protocol ADO Protocol +193.85%
#2 GoPlus Security GoPlus Security +36.55%
#3 GAIB AID GAIB AID +24.67%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +19.22%
#5 Tutorial Tutorial +16.90%
#6 SkyAI SkyAI +16.67%
#7 Pons Pons +13.86%
#8 Verus Coin Verus Coin +13.11%
#9 Status Status +12.83%
#10 o1.exchange o1.exchange +12.80%
Coin of the day
ADO Protocol ADO Protocol
Paramètres
Langue
FRANçAIS
Devise
USD
Thème
NeuroMetrix, Inc. NeuroMetrix, Inc.

NeuroMetrix, Inc.

NURO
Classement en actions #33744
NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing,... NeuroMetrix, Inc. is a healthcare company focused on creating, manufacturing, and distributing medical devices that stimulate and evaluate nerve function for both diagnostic and therapeutic applications. These products are available across a wide geographical area, including the United States, Europe, Japan, China, the Middle East, and Mexico. The company's core offerings include DPNCheck, a nerve conduction test used to identify and assess peripheral neuropathies such as diabetic peripheral neuropathy; Quell, a wearable device engineered for the relief and management of persistent pain; and the ADVANCE system, a dedicated platform for performing comprehensive nerve conduction studies. NeuroMetrix supplies its advanced solutions to a diverse clientele, encompassing managed care organizations, primary care providers, specialists like endocrinologists, podiatrists, various surgeons (including orthopedic and hand surgeons), occupational health practitioners, and neurology, pain medicine, and physical medicine and rehabilitation experts. Incorporated in 1996, the company's headquarters are located in Woburn, Massachusetts.
Prix de l'action
$4.58
Dernière synchronisation: 2025-05-09
Capitalisation boursière
$6.98M
Changement (1 jour)
0.00%
Changement (1 an)
0.00%
Pays
US
Échange NeuroMetrix, Inc. (NURO)

Catégorie

Healthcare
Ratio P/S pour NeuroMetrix, Inc. (NURO)
Ratio P/S au August 2026 TTM : 3.11
Selon les derniers rapports financiers et le cours de l'action de NeuroMetrix, Inc., le ratio cours/ventes actuel (TTM) est 3.11. À la fin de 2023, le ratio P/S était de 0.64.
Historique du ratio P/S pour NeuroMetrix, Inc. de 2001 à 2026
Ratio P/S à la fin de chaque année
Année Ratio P/S Changez
2026 (TTM) 3.11 20.56%
2024 2.58 305.89%
2023 0.64 -50.63%
2022 1.29 -89.69%
2021 12.48 -3.81%
2020 12.98 194.44%
2019 4.41 54.39%
2018 2.85 107.21%
2017 1.38 -58.19%
2016 3.30 -62.48%
2015 8.78 -61.93%
2014 23.07 -12.31%
2013 26.31 351.05%
2012 5.83 57.37%
2011 3.71 -58.86%
2010 9.01 -28.96%
2009 12.68 312.90%
2008 3.07 -85.25%
2007 20.83 -22.83%
2006 26.98 -65.07%
2005 77.26 22.47%
2004 63.09 -22.35%
2003 81.25 -53.91%
2002 176.30 -18.00%
2001 215.00 0.00%
Ratio P/S pour des entreprises similaires ou concurrentes
Entreprise Ratio P/S Différence de Ratio P/S Pays
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
4.13 32.87%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
5.03 61.82%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
2.78 -10.46%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
3.67 17.97%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
8.10 160.38%
US